Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol

Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol

Abstract Background Oral antiretroviral therapy (ART) has been effective at reducing mortality rates of people with HIV. However, despite its effectiveness, people who use drugs face barriers to maintaining ART adherence. Receipt of opioid agonist treatment, in the context of HIV care, is associated...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Kirsten J. Langdon, Anthony E. Hitch, Alexandra B. Collins, Curt G. Beckwith, Sara Becker, Karen Tashima, Josiah D. Rich
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2023-10-01
Sarja:Addiction Science & Clinical Practice
Aiheet:
Opioid use disorder
HIV
Medications for opioid use disorder
Long-acting injectable medication
Antiretroviral therapy
Antiviral resistance
Linkit:https://doi.org/10.1186/s13722-023-00418-6

Internet

https://doi.org/10.1186/s13722-023-00418-6

Samankaltaisia teoksia